SHShin Hisahara

Shin Hisahara

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Shin Hisahara has a total of 120 co-authors. Here are the top co-authors by number of shared publications:

  • Kazuki Yokokawa

    Department of Neurology, School of Medicine Sapporo Medical University Sapporo Hokkaido Japan

    10 shared publications
  • Syuuichirou Suzuki

    Department of Neurology, School of Medicine Sapporo Medical University Sapporo Hokkaido Japan

    10 shared publications
  • Kazuna Ikeda

    Department of Neurology, School of Medicine Sapporo Medical University Sapporo Hokkaido Japan

    7 shared publications
  • Shun Shimohama

    Department of Neurology, Sapporo Medical University, School of Medicine, Japan

    7 shared publications
  • Shun Shimohama

    Department of Neurology, School of Medicine, Sapporo Medical University, Sapporo 060-8543, Japan

    7 shared publications
  • Akihiro Matsumura

    Department of Neurology, Sapporo Medical University School of Medicine, Japan

    6 shared publications

Latest Publications

  • Marked Peripheral Blood Plasmablast Expansion in MOG Antibody‐Associated Disease and Anti‐ NMDA Receptor Encephalitis Overlap Syndrome

    by Takuya Okamoto, Masanobu Tanemoto, Kazuki Yokokawa, Bungo Hirose, Naotoshi Iwahara, Ippei Ikegami, Syuuichirou Suzuki, Shin Hisahara

    Following upper respiratory symptoms, a 30‐year‐old man developed right eye pain, psychiatric symptoms, cognitive decline, and status epilepticus. Brain MRI showed unilateral cortical FLAIR hyperintensity consistent with FLAMES (FLAIR‐hyperintense lesions in anti‐MOG‐associated encephalitis with seizures). Serum anti‐MOG antibodies and cerebrospinal fluid (CSF) anti‐NMDAR antibodies established MOG antibody‐associated disease (MOGAD) and anti‐NMDAR encephalitis overlapping syndrome (MNOS). Flow cytometry revealed marked expansion of peripheral blood plasmablasts (IgD − CD19 + CD20 − CD24 − CD27 + CD38 + CD138 − ), comprising 13.6% of peripheral blood B cells, whereas CSF B cells were predominantly naïve B cells with virtually no detectable plasmablasts and plasma cells. Following immunotherapy, peripheral blood plasmablasts decreased to 2.0% in parallel with clinical recovery, while CSF B cells shifted toward memory predominance. This case demonstrates a dissociation between peripheral blood plasmablast expansion and absent intrathecal plasmablast accumulation in MNOS, suggesting that peripheral blood B‐cell profiling may warrant further evaluation in MNOS.

  • Autoimmune Epilepsy With Isolated Serum Positivity for Anti–Gamma‐Aminobutyric Acid Type A Receptor Antibodies: A Case Report

    by Kazuki Yokokawa, Taro Saito, Naotoshi Iwahara, Masanobu Tanemoto, Kazuna Ikeda, Minoru Yamada, Reiko Tsuda, Syuuichirou Suzuki, Kenta Tasaki, Makoto Hara, et al.

    A 67‐year‐old woman has experienced recurrent generalized seizures since 2022 and was admitted to our department on multiple occasions. No neurological deficits or cerebrospinal fluid (CSF) abnormalities were observed during the interictal periods. Brain MRI revealed multifocal, reversible cortical–subcortical FLAIR hyperintense lesions. Antiepileptic drugs were administered, and the patient has remained seizure‐free. Epilepsy due to an immune‐mediated mechanism was suspected. Anti‐gamma‐aminobutyric acid type A (GABA A ) receptor antibodies were identified in the serum but not in the CSF using a cell‐based assay. Although GABA A receptor antibodies are typically detectable in both serum and CSF, several reports have described cases with serum‐only positivity. Our case highlights that autoimmune epilepsy may present without overt encephalitic features and with isolated serum antibody positivity. Therefore, negative CSF results do not necessarily exclude antibody‐mediated disease, and concurrent testing of both serum and CSF is recommended in clinical practice.

  • Open Access

    Response to SARS-CoV-2 Infection in Sjögren Syndrome Can Be Complicated by Myelitis and Guillain-Barré Syndrome

    by Takumi Funakoshi, Minoru Yamada, Kazuna Ikeda, Kazuki Yokokawa, Tarou Saito, Reiko Tsuda, Naotoshi Iwahara, Syuuichirou Suzuki, Shin Hisahara

  • Open Access

    Sjögren's Syndrome with Sensory Neuronopathy and Polyradiculoneuropathy

    by Takumi Funakoshi, Minoru Yamada, Kazuna Ikeda, Kazuki Yokokawa, Tarou Saito, Reiko Tsuda, Naotoshi Iwahara, Syuuichirou Suzuki, Shin Hisahara

    41-year-old female became difficulty walking due to sensory ataxia in the limbs and trunk. A diagnosis of Sjögren's syndrome was made on the results of positive anti-SS-A antibody and a lip gland biopsy. Nerve conduction studies indicated sensory neuronopathy. The symptoms improved following treatment with plasma exchange, intravenous immunoglobulin, and intravenous methylprednisolone. Nine months later, the patient's sensory ataxia worsened. Nerve conduction studies revealed the coexistence of sensory neuronopathy and polyradiculoneuropathy. The symptoms improved following treatment with intravenous cyclophosphamide and intravenous immunoglobulin. This case represents the first instance of sensory neuronopathy and polyradiculoneuropathy coexisting as Sjögren's syndrome related neuropathy.


  • Open Access

    Elevated ITGAX/CD11c in CSF-Derived Extracellular Vesicles Reflects Disability Progression in Multiple Sclerosis

    by Naotoshi Iwahara, Satoshi Muraoka, Taro Saito, Masayo Hirano, Kazuki Yokokawa, Masanobu Tanemoto, Ryosuke Oda, Takayuki Nonaka, Shuuichirou Suzuki, Jun Adachi, et al.

    Extracellular vesicles (EVs) are membrane-bound particles that are released into the extracellular space and are believed to play a role in the pathogenesis of neuroinflammation and neurodegeneration. Nevertheless, the precise role of these vesicles in the context of multiple sclerosis (MS) remains uncertain. The objective of this study was to identify the distinctive characteristics of EVs associated with MS. EVs were isolated from CSF using phosphatidylserine affinity methods. Mass spectrometry was used to analyze CSF samples and EVs isolated from those CSF samples collected from a discovery cohort of 10 patients with other neurologic diseases (ONDs) and 10 patients with MS. In addition, mass spectrometry was used to analyze EVs isolated from CSF samples in a validation cohort of 24 patients with ONDs, 38 patients with MS, and 14 patients with neuromyelitis optica spectrum disorders. The results revealed notable increases in the levels of 33 proteins in the CSF samples and 100 proteins in the CSF-derived EVs from patients with MS in the validation cohort. Increases in the levels of ITGA4, ITGAX (CD11c), MS4A1 (CD20), CD3E, CD4, and CD8A, which are marker proteins of lymphocytes and myeloid cells, including activated microglia and dendritic cells, were observed in the CSF-derived EVs in the discovery cohort. The results of the validation cohort revealed that the levels of 4 proteins, ITGA4, ITGAX, MS4A1, and CD3E, were significantly greater in patients with MS than in patients with ONDs. Furthermore, the level of ITGAX was greater in the patients with confirmed disability worsening (CDW) than in those without CDW. The results of the receiver operating characteristic (ROC) and Kaplan-Meier analyses indicated that ITGAX levels in CSF-derived EVs may prove useful in predicting disease prognosis. Our findings suggest that CSF-derived EVs reflect immunologic changes in MS and other neuroimmune diseases. In addition, these results raise the possibility that changing in myeloid cells and lymphocytes may also play a role in the pathogenesis of MS. CSF-derived EVs may serve as indicators of MS disease severity and could be used as biomarkers in the future.


  • Open Access

    A Case of Multiple Intracerebral Hemorrhages Due to Early-Onset Cerebral Amyloid Angiopathy With Alzheimer’s Disease: Neuropathological Changes Three Decades After Childhood Neurosurgery

    by Takumi Funakoshi, Minoru Yamada, Kazuna Ikeda, Kazuki Yokokawa, Taro Saito, Naotoshi Iwahara, Syuuichirou Suzuki, Yusuke Kimura, Yukinori Akiyama, Nobuhiro Mikuni, et al.

    Cerebral amyloid angiopathy (CAA) is a disease in which amyloid beta (Aβ) is deposited in blood vessels and meninges in the brain. Cerebral amyloid angiopathy typically occurs in the elderly but is also known to occur in younger patients with a history of childhood head trauma or dura graft following neurosurgical procedures.

  • Open Access

    Transthyretin Variant Amyloidosis with a TTR A97D (p.A117D) Mutation Manifesting Remarkable Asymmetric Neuropathy

    by Kazuna Ikeda, Daisuke Yamamoto, Keiko Usui, Hiroki Takeuchi, Nobuyuki Oka, Nagaaki Katoh, Masahide Yazaki, Fuyuki Kametani, Ichizo Nishino, Shin Hisahara

    We herein report a 68-year-old Japanese man with sporadic variant transthyretin (ATTRv) amyloidosis harboring the novel variant A97D (p.A117D) in TTR. He had slow development of asymmetric neuropathy, unintentional weight loss, mild autonomic failure and mild cardiomyopathy. TTR amyloid deposition on the gastric duodenal mucosa was detected. In silico analyses predicted that TTR A97D (p.A117D) altered the structure and function of the TTR protein. ATTRv amyloidosis is often difficult to diagnose in non-endemic regions due to its diverse phenotypes, such as atypical peripheral nerve involvement and a rare family history.


  • Open Access

    Anti-signal Recognition Particle Antibody-positive Immune-mediated Myopathy after mRNA-1273 SARS-CoV-2 Vaccination

    by Masanobu Tanemoto, Ryosuke Oda, Yuichiro Toyama, Hirohiko Shizukawa, Kazuki Yokokawa, Taro Saito, Syuuichirou Suzuki, Akihiro Matsumura, Shin Hisahara

    A 26-year-old Japanese woman developed a fever, myalgia and gait disturbance one day after receiving the second dose of the mRNA-1273 severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine. A neurological examination revealed symmetrical weakness and myalgia in proximal lower limbs, and a blood examination showed prominent elevation of creatinine kinase. Magnetic resonance imaging (MRI) revealed a high signal intensity in the thigh muscles on short-tau inversion recovery images, and antibody testing revealed positive findings for anti-signal recognition particle (SRP) antibody. Thus, anti-SRP antibody-positive immune-mediated myopathy was diagnosed. We initiated immunotherapy, and she was ultimately able to walk stably.


  • Open Access

    Cerebral Tuberculoma Diagnosed by Nested Polymerase Chain Reaction of a Formalin-fixed Paraffin-embedded Brain Biopsy Sample

    by Morihiro Yamamoto, Tatsuo Manabe, Kazuki Yokokawa, Kazufumi Tsuzaka, Minoru Yamada, Rei Miyanaga, Taro Saito, Daisuke Yamamoto, Akihiro Matsumura, Syuuichirou Suzuki, et al.

    A 38-year-old man was taken to hospital with generalized clonic seizure. Brain magnetic resonance imaging (MRI) showed multiple ring-enhancing lesions centered in the left frontoparietal lobe. A histopathological examination of a brain biopsy sample revealed granulomatous lesions with caseous necrosis. We extracted DNA from a formalin-fixed paraffin-embedded (FFPE) brain specimen, and nested polymerase chain reaction (PCR) of the DNA sample detected the Mycobacterium tuberculosis-specific insertion sequence IS6110. The lesions worsened after anti-tuberculosis drugs were administered, which we considered to be a paradoxical response and continued treatment. A genetic diagnosis of M. tuberculosis using FFPE specimens is useful for diagnosing tuberculoma.


  • Open Access

    Sporadic Amyotrophic Lateral Sclerosis Due to a FUS P525L Mutation with Asymmetric Muscle Weakness and Anti-ganglioside Antibodies

    by Masanobu Tanemoto, Shin Hisahara, Kazuna Ikeda, Kazuki Yokokawa, Tatsuo Manabe, Reiko Tsuda, Daisuke Yamamoto, Takashi Matsushita, Akihiro Matsumura, Syuuichirou Suzuki, et al.

    Amyotrophic lateral sclerosis (ALS) due to a fused in sarcoma (FUS) P525L mutation is characterized by a rapidly progressive course. Multifocal motor neuropathy (MMN) may resemble ALS in early stage and is associated with anti-ganglioside antibodies. A 38-year-old woman was admitted to our hospital because of progressive muscle weakness in the right limbs. She had mild mental retardation and minor deformities. Initially, we suspected MMN given the asymmetric muscle weakness and detection of anti-ganglioside antibodies. However, physical and electrophysiological tests did not support MMN, instead suggesting ALS. We confirmed a heterozygous P525L mutation and finally diagnosed this case as ALS due to an FUS mutation.